FAQ: Quantum BioPharma Licensee Unbuzzd Wellness Investor Webinar and Business Overview
Summary
Quantum BioPharma's licensee Unbuzzd Wellness is hosting an investor webinar on October 30, 2025, as part of a $5 million fundraising effort for its scientifically proven beverage that accelerates alcohol metabolism and reduces hangover symptoms, with no dilution to Quantum shareholders.
What is the main announcement in this content?
Quantum BioPharma’s licensee, Unbuzzd Wellness Inc., will host an investor webinar on October 30, 2025, as part of its Reg D 506(c) offering and up to $5 million raise for the unbuzzd(TM) beverage product.
When is the Unbuzzd Wellness investor webinar taking place?
The webinar is scheduled for October 30, 2025, at 4:15 p.m. ET (1:15 p.m. PT).
Who are the key participants in the investor webinar?
The event will feature Unbuzzd CEO John Duffy, Advisor Jason Sawyer, Medical Director Dr. Eric Hoskins, and Board Co-Chair Gerry David, former CEO of Celsius.
What is unbuzzd(TM) and what does it do?
unbuzzd(TM) is a scientifically proven beverage that accelerates alcohol metabolism, restores mental clarity, and reduces hangover symptoms.
What is Quantum BioPharma’s relationship with Unbuzzd Wellness?
Quantum BioPharma invented unbuzzd(TM) and spun out its OTC version to Unbuzzd Wellness, retaining 20.11% ownership (as of March 31, 2025) and receiving 7% royalty payments on sales until $250 million is reached, then 3% in perpetuity.
What are Quantum BioPharma’s main areas of focus?
Quantum BioPharma focuses on developing treatments for neurodegenerative and metabolic disorders and alcohol misuse disorders, with lead compound Lucid-MS for multiple sclerosis and strategic investments through FSD Strategic Investments Inc.
How does this fundraising affect Quantum BioPharma shareholders?
The Unbuzzd Wellness fundraising involves no dilution to Quantum BioPharma shareholders.
What rights does Quantum BioPharma retain for unbuzzd(TM)?
Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses.
Where can investors find more information about Quantum BioPharma?
The latest news and updates relating to QNTM are available in the company’s newsroom at https://ibn.fm/QNTM
What will be discussed during the investor webinar?
The webinar will cover the investment opportunity for unbuzzd(TM), leadership strategy, distribution plans, and include a Q&A session with company executives.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 262706